Transderm-induced psychosis in Parkinson's disease

Neurology

Volumn 53, Issue 2, 1999, Pages 433-434

  Minagar, Alireza ^a   Shulman, Lisa M ^a   Weiner, William J ^a   Attarian, Hrayr P ^b  

^a STRONG MEMORIAL HOSPITAL   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; BELLADONNA ALKALOID; CARBIDOPA; CHOLINERGIC RECEPTOR STIMULATING AGENT; LEVODOPA; MIDODRINE; PRAMIPEXOLE; SCOPOLAMINE; SELEGILINE; TRANSDERM; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CASE REPORT; CHOLINERGIC SYSTEM; DELUSION; DRUG SAFETY; DRUG WITHDRAWAL; FEMALE; HALLUCINATION; HUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; PSYCHOSIS; TRANSDERMAL DRUG ADMINISTRATION;

EID: 0033595187     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/wnl.53.2.433-a     Document Type: Article

References (7)

1. Shear NH, Spielberg SP. Anticonvulsant hypersensitivity syndrome: in vitro assessment of risk. J Clin Invest 1988;82:1826-1832.
2. Epstein A, Barland P. The diagnostic value of antihistone antibodies in drug-induced lupus erythematosus. Arthritis Rheum 1985;28:158-162.
3. Drory VE, Korczyn AD. Hypersensitivity vasculitis and systemic lupus erythematosus induced by anticonvulsants. Clin Neuropharmacol 1993; 16:19-29.
4. Yung RL, Richardson BC. Drug-induced lupus. Rheum Dis Clin North Am 1994;20:61-86.
5. McCarty GA. Autoantibodies and their relation to rheumatic diseases. Med Clin North Am 1986;70:237-257.
6. Maddison PJ, Skinner RP, Pereira RS, et al. Antinuclear antibodies in the relatives and spouses of patients with systemic sclerosis. Ann Rheum Dis 1986;45:793-799.
7. Singsen BH, Fishman L, Hanson V. Antinuclear antibodies and lupus-like syndromes in children receiving anticonvulsants. Pediatrics 1976; 57:529-534.